Carregue numa fotografia para ir para os Livros Google.
|
A carregar... Bad Blood: Secrets and Lies in a Silicon Valley Startup (original 2018; edição 2018)por John Carreyrou (Autor)
Informação Sobre a ObraBad Blood: Secrets and Lies in a Silicon Valley Startup por John Carreyrou (2018)
   Ainda não há conversas na Discussão sobre este livro.  Levitara | Apr 5, 2024 |   In the span of 10 years Theranos, the start-up which Holmes created, went from a little blood testing machine to, well, a little non-functioning blood testing machine. Through quick thinking, being evasive and using outside testing facilities for accurate results was she was able to receive the backing of the US Army and former Secretaries of State, George Schultz and Henry Kissinger. How does this flimsy start-up come to an end? A phone call to a Wall Street Journal journalist named John Carryrou from a suspicious employee. (  ) Carmenere | Apr 2, 2024 |  ) guildlingsfan | Mar 28, 2024 | ) aleshh | Jan 12, 2024 | ) hellokirsti | Jan 3, 2024 |
 The author’s description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist; Carreyrou wisely lets the evidence speak for itself. As presented here, Holmes harbored delusions of grandeur but couldn’t cope with the messy realities of bioengineering. Swathed in her own reality distortion field, she dressed in black turtlenecks to emulate her idol Jobs and preached that the Theranos device was “the most important thing humanity has ever built.” Employees were discouraged from questioning this cultish orthodoxy by her “ruthlessness” and her “culture of fear.” Secrecy was obsessive. Labs and doors were equipped with fingerprint scanners. PrémiosDistinctionsNotable Lists
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- Não foram encontradas descrições de bibliotecas. |
Current DiscussionsNenhum(a)Capas populares
 Google Books — A carregar...GénerosSistema Decimal de Melvil (DDC)338.7Social sciences Economics Production Business EnterprisesClassificação da Biblioteca do Congresso dos EUA (LCC)AvaliaçãoMédia: (4.31)
É você?Torne-se num Autor LibraryThing. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10
(